scispace - formally typeset
J

J. O. M. Pobee

Researcher at University of Zambia

Publications -  13
Citations -  1231

J. O. M. Pobee is an academic researcher from University of Zambia. The author has contributed to research in topics: Tuberculosis & Tuberculin. The author has an hindex of 12, co-authored 13 publications receiving 1214 citations.

Papers
More filters
Journal ArticleDOI

Impact of HIV on tuberculosis in Zambia: a cross sectional study.

TL;DR: The high prevalence of HIV in patients with tuberculosis suggests that an epidemic of reactivating tuberculosis is arising in those who are infected with HIV, and the redirection of public health priorities towards tuberculosis would focus on a major treatable and preventable complication of the AIDS epidemic.
Journal ArticleDOI

Twice weekly tuberculosis preventive therapy in HIV infection in Zambia

TL;DR: It is demonstrated that preventive therapy with either twice weekly isoniazid for 6 months or a combination of rifampicin and pyrazinamide for 3 months reduced the incidence of TB in HIV-infected persons in Zambia.
Journal ArticleDOI

Negative sputum smear results in HIV-positive patients with pulmonary tuberculosis in Lusaka, Zambia

TL;DR: The findings imply that cases of HIV-associated pulmonary tuberculosis may frequently be missed and emphasise the need for new diagnostic methods.
Journal Article

The impact of human immunodeficiency virus on presentation and diagnosis of tuberculosis in a cohort study in Zambia.

TL;DR: Two hundred and forty-nine patients with tuberculosis were recruited to a cohort study to investigate the interaction between tuberculosis and HIV in Lusaka, Zambia; findings at presentation are presented here.
Journal ArticleDOI

The impact of human immunodeficiency virus on mortality of patients treated for tuberculosis in a cohort study in Zambia

TL;DR: Risk factors for death in HIV-positive patients included multi-site tuberculosis, history of prolonged diarrhoea or fever, oral thrush, splenomegaly, anergy to tuberculin, low weight, anaemia or lymphopenia, and poor compliance with regimens containing rifampicin and pyrazinamide.